⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
SGMT News
Sagimet Biosciences Inc. Series A Common Stock
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Provides Strategic and Corporate Updates
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
OMER
AMGN
Sagimet Biosciences Announces Appointment of Andreas Grauer, MD, as Chief Medical Officer
globenewswire.com
SGMT
OMER
Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
SGMT
Form 8-K
sec.gov
SGMT
Sagimet Biosciences Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Updates
globenewswire.com
SGMT
Sagimet Biosciences Announces Participation in Three Upcoming Investor Conferences
globenewswire.com
SGMT
Sagimet Biosciences Announces Participation in Two Upcoming Investor Conferences
globenewswire.com
SGMT
Sagimet Announces Positive 52-Week Data from License Partner Ascletis’ Open-Label Phase 3 Clinical Trial Evaluating the Long-Term Safety of ASC40 (Denifanstat) Tablets in Patients with Moderate to Severe Acne
globenewswire.com
SGMT